SCHEMBL407973

SCHEMBL407973

O=C1CCC(=S)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2174687 0.82
SCHEMBL570139 0.82
Succinimide SCHEMBL1600526 0.75
Succinimide SCHEMBL8361206 0.75 CRBN (1.00)
Succinimide SCHEMBL774 0.75
Succinimide SCHEMBL1326078 0.75 CRBN (1.00)
Succinimide SCHEMBL1466558 0.75
Succinimide SCHEMBL869607 0.73 CRBN (0.79)
Succinimide SCHEMBL9336599 0.72
Succinimide SCHEMBL10784113 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3352 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946460-B1 IMPROVED CONJUGATION LINKERS PROLYNX LLC (US) 2026-05-20 EP claimed
EP-4727583-A1 T CELL ENGAGER MASKING MOLECULES AMGEN INC. (US) 2026-04-22 EP claimed
EP-4704904-A1 TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD Tambo, Inc. (US) 2026-03-11 EP claimed
EP-4682154-A1 PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF OLIGOSACCHARIDES REPRESENTING SEGMENTS OF O-ANTIGENS FROM DIVERSE SHIGELLA FLEXNERI SEROTYPES Institut Pasteur (FR) 2026-01-21 EP claimed
US-20250387503-A1 DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S (DK) 2025-12-25 US claimed
EP-4646231-A1 DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS Ascendis Pharma Ophthalmology Division A/S (DK) 2025-11-12 EP claimed
EP-4199970-B1 EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS RIGSHOSPITALET (DK) 2025-10-15 EP claimed
EP-4615476-A2 PREPARATION OF LIPID NANOPARTICLE (LNP) CONJUGATES Tessera Therapeutics, Inc. (US) 2025-09-17 EP claimed
EP-4598980-A2 COMPOSITIONS FOR MICROFLUDIC WORKFLOWS AND METHODS OF USE THEREOF Bruker Cellular Analysis, Inc. (US) 2025-08-13 EP claimed
US-20250250397-A1 ANISOTROPIC POLY(ETHYLENE GLYCOL)-BASED HYDROGELS SYNTHESIZED VIA TWO-STAGE POLYMERIZATION AND MECHANICAL ALIGNMENT UNIVERSITY OF OREGON (US) 2025-08-07 US claimed
CN-1935790-A Method for synthesizing N-hydroxy thiosuccinimide salt ENZI PHARMACEUTICAL NANJING CO (CN) 2007-03-28 CN claimed
US-20070020224-A1 Protein-proteophore complexes ASCENDIS PHARMA GMBH (DE) 2007-01-25 US claimed
CN-1268346-C Biological polysaccharide micro-capsule, prepn. method and application thereof ZHONGKE WUBAIHAO BIOLOG ENGINE (CN) 2006-08-09 CN claimed
EP-1682186-A2 HYPERBRANCHED POLYMER CONJUGATES VIA NON-ENZYMATIC CLEAVABLE LINKER Complex Biosystems GmbH (DE) 2006-07-26 EP claimed
CN-1618434-A Biological polysaccharide micro-capsule, prepn. method and application thereof ZHONGKE WUBAIHAO BIOLOG ENGINE (CN) 2005-05-25 CN claimed
EP-1525890-A1 Protein-Proteophore complexes Complex Biosystems GmbH (DE) 2005-04-27 EP claimed
WO-2005034909-A2 HYPERBRANCHED POLYMER CONJUGATES VIA NON-ENZYMATIC CLEAVABLE LINKER COMPLEX BIOSYSTEMS GMBH (DE) 2005-04-21 WO claimed
CN-1458525-A Integrated capillary biological chip and its producing method GUO ZHANJUN (CN) 2003-11-26 CN claimed
CN-1438244-A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof GUO ZHANJUN (CN) 2003-08-27 CN claimed
US-4001025-A SILVER SULFIDE, DIGESTION MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1977-01-04 US claimed